
Real-world acne treatment adherence spans 6% to 84%, with cost, adverse effects, and slow results driving nonadherence.
Hospitals that have grappled with how best to curb length of stay while also preventing readmissions may find comfort in a new study that suggests that a drop in the former does not necessarily mean a greater number of the latter.
Using 14 years of data from 129 Veterans Affairs hospitals, researchers concluded that an overall reduction in risk-adjusted length of stay was not associated with a corresponding spike in 30-day readmission rates, according to the VA-funded study, published Monday in the Annals of Internal Medicine.
Read the full story:
Source: ModernHealthcare.com





